200 related articles for article (PubMed ID: 17188178)
21. [Determination of the diagnostic accuracy of 99mTc sestamibi scanning in patients with thyroid nodule and a definitive histopathological report].
Beristain Hernández JL; Servín Torres E; Sosa Caballero A; Velázquez García JA; Pozzo Bobarín R; Delgadillo Teyer G; Serrano Galeana I; Márquez Hernández A; Bevia Pérez F; Piscil Salazar MA; Ortiz De La Peña Salazar Ilarregui D; Sánchez González FJ; Espinoza Aguilar A
Endocrinol Nutr; 2010 Dec; 57(10):460-6. PubMed ID: 21035410
[TBL] [Abstract][Full Text] [Related]
22. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
[TBL] [Abstract][Full Text] [Related]
23. Endocrine incidentalomas.
Starker LF; Prieto PA; Liles JS; Tran Cao HS; Grubbs EG; Lee JE; Perrier ND; Graham PH
Curr Probl Surg; 2016 May; 53(5):219-46. PubMed ID: 27325542
[No Abstract] [Full Text] [Related]
24. [Surgery of the thyroid nodule. Current treatment].
Tamames Gómez S
An R Acad Nac Med (Madr); 2006; 123(3):659-66; discussion 667-9. PubMed ID: 17451104
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology.
Boi F; Lai ML; Deias C; Piga M; Serra A; Uccheddu A; Faa G; Mariotti S
Eur J Endocrinol; 2003 Dec; 149(6):493-8. PubMed ID: 14640989
[TBL] [Abstract][Full Text] [Related]
26. Assessing thyroid malignancy with double-phase scintigraphy using technetium-99m-MIBI.
Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A
J Nucl Med; 1998 Jan; 39(1):215-6. PubMed ID: 9443764
[No Abstract] [Full Text] [Related]
27. Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute tc-99m MIBI scans.
Sharma R; Mondal A; Shankar LR; Sahoo M; Bhatnagar P; Sawroop K; Chopra MK; Kashyap R
Clin Nucl Med; 2004 Sep; 29(9):534-7. PubMed ID: 15311117
[TBL] [Abstract][Full Text] [Related]
28. Autonomous thyroid nodules visualized by positron emission tomography with 18F-fluorodeoxyglucose: a case report and review of the literature.
Gianoukakis AG; Karam M; Cheema A; Cooper JA
Thyroid; 2003 Apr; 13(4):395-9. PubMed ID: 12804108
[TBL] [Abstract][Full Text] [Related]
29. Management guidelines for patients with thyroid nodules.
Serpell J
ANZ J Surg; 2010 Nov; 80(11):765-6. PubMed ID: 20969681
[No Abstract] [Full Text] [Related]
30. Multi-tracer imaging of thyroid nodules: is there a role in the preoperative assessment of nodular goiter?
Lind P
Eur J Nucl Med; 1999 Aug; 26(8):795-7. PubMed ID: 10436189
[No Abstract] [Full Text] [Related]
31. [Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
Sebastianes FM; Cerci JJ; Soares Júnior J; Zanoni PH; Tomimori EK; Camargo RY; Meneghetti JC; Pereira MA
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1176-83. PubMed ID: 19082307
[TBL] [Abstract][Full Text] [Related]
32. Functional and molecular thyroid imaging.
Giovanella L; Petranović Ovčariček P
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):86-92. PubMed ID: 35166094
[TBL] [Abstract][Full Text] [Related]
33. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
[TBL] [Abstract][Full Text] [Related]
34. Double-phase scanning of the thyroid gland with Tc-99m MIBI in a patient with a malignant nodule. A case of tracer redistribution?
Alonso O; Mut F; Lago G; Nuñez M; Touya E
Clin Nucl Med; 1997 Jun; 22(6):413-4. PubMed ID: 9193822
[No Abstract] [Full Text] [Related]
35. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
Biscontini G; Possa M; Sara R; Milella M; Rossetti C
Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
[TBL] [Abstract][Full Text] [Related]
36. Multifocal hyperfunctioning thyroid carcinoma without metastases.
Nishida AT; Hirano S; Asato R; Tanaka S; Kitani Y; Honda N; Fujiki N; Miyata K; Fukushima H; Ito J
Auris Nasus Larynx; 2008 Sep; 35(3):432-6. PubMed ID: 17826928
[TBL] [Abstract][Full Text] [Related]
37. Thyroid nodules with indeterminate cytology: molecular imaging with ⁹⁹mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma gene expression classifier.
Heinzel A; Müller D; Behrendt FF; Giovanella L; Mottaghy FM; Verburg FA
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1497-500. PubMed ID: 24705621
[TBL] [Abstract][Full Text] [Related]
38. Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules.
Hurtado-López LM; Martínez-Duncker C
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1701-3. PubMed ID: 17581750
[No Abstract] [Full Text] [Related]
39. The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.
Vriens D; de Wilt JH; van der Wilt GJ; Netea-Maier RT; Oyen WJ; de Geus-Oei LF
Cancer; 2011 Oct; 117(20):4582-94. PubMed ID: 21432844
[TBL] [Abstract][Full Text] [Related]
40. The patient with a thyroid nodule.
Miller MC
Med Clin North Am; 2010 Sep; 94(5):1003-15. PubMed ID: 20736109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
